117 related articles for article (PubMed ID: 8075054)
21. Efficacy and safety of selective internal radiotherapy with yttrium-90 resin microspheres compared with sorafenib in locally advanced and inoperable hepatocellular carcinoma (SARAH): an open-label randomised controlled phase 3 trial.
Vilgrain V; Pereira H; Assenat E; Guiu B; Ilonca AD; Pageaux GP; Sibert A; Bouattour M; Lebtahi R; Allaham W; Barraud H; Laurent V; Mathias E; Bronowicki JP; Tasu JP; Perdrisot R; Silvain C; Gerolami R; Mundler O; Seitz JF; Vidal V; Aubé C; Oberti F; Couturier O; Brenot-Rossi I; Raoul JL; Sarran A; Costentin C; Itti E; Luciani A; Adam R; Lewin M; Samuel D; Ronot M; Dinut A; Castera L; Chatellier G;
Lancet Oncol; 2017 Dec; 18(12):1624-1636. PubMed ID: 29107679
[TBL] [Abstract][Full Text] [Related]
22. Phase II study of Erlotinib (OSI-774) in patients with advanced hepatocellular cancer.
Philip PA; Mahoney MR; Allmer C; Thomas J; Pitot HC; Kim G; Donehower RC; Fitch T; Picus J; Erlichman C
J Clin Oncol; 2005 Sep; 23(27):6657-63. PubMed ID: 16170173
[TBL] [Abstract][Full Text] [Related]
23. A phase II study of epirubicin and thalidomide in unresectable or metastatic hepatocellular carcinoma.
Zhu AX; Fuchs CS; Clark JW; Muzikansky A; Taylor K; Sheehan S; Tam K; Yung E; Kulke MH; Ryan DP
Oncologist; 2005; 10(6):392-8. PubMed ID: 15967833
[TBL] [Abstract][Full Text] [Related]
24. [Hepatic arterial infusion chemotherapy using totally implantable port system].
Takayasu Y; Yamamoto S; Ikeda J
Gan To Kagaku Ryoho; 2000 Sep; 27(10):1516-20. PubMed ID: 11015995
[TBL] [Abstract][Full Text] [Related]
25. [Molecular therapy for HCC?].
Greten TF
Z Gastroenterol; 2006 Feb; 44(2):205-6. PubMed ID: 16456763
[No Abstract] [Full Text] [Related]
26. A phase II trial of recombinant leukocyte interferon plus doxorubicin in patients with hepatocellular carcinoma.
Feun LG; Savaraj N; Hung S; Reddy R; Jeffers L; Benedetto P; Livingstone AS; Ardalan B; Levi JU; Parker T
Am J Clin Oncol; 1994 Oct; 17(5):393-5. PubMed ID: 8092109
[TBL] [Abstract][Full Text] [Related]
27. Phase II study of co-administration of uracil and tegafur (UFT) in hepatocellular carcinoma. Tokyo Liver Cancer Chemotherapy Study Group.
Jpn J Clin Oncol; 1985 Sep; 15(3):559-62. PubMed ID: 2997511
[TBL] [Abstract][Full Text] [Related]
28. A phase II study of etoposide in patients with hepatocellular carcinoma by the Tokyo Liver Cancer Chemotherapy Study Group.
Yoshino M; Okazaki N; Yoshida T; Kanda Y; Miki M; Oda H; Sasagawa Y; Hayashi S; Hashimoto N
Jpn J Clin Oncol; 1989 Jun; 19(2):120-2. PubMed ID: 2471845
[TBL] [Abstract][Full Text] [Related]
29. [Therapeutic results using VP 16-213 alone or in combination with 5-fluorouracil in liver cancer (hepatoma)].
Cavalli F; Tschopp L; Gerber A; Sonntag RW; Ryssel HJ; Brunner KW
Schweiz Med Wochenschr; 1977 Dec; 107(52):1960-6. PubMed ID: 202020
[TBL] [Abstract][Full Text] [Related]
30. Phase 2 study of erlotinib in patients with unresectable hepatocellular carcinoma.
Thomas MB; Chadha R; Glover K; Wang X; Morris J; Brown T; Rashid A; Dancey J; Abbruzzese JL
Cancer; 2007 Sep; 110(5):1059-67. PubMed ID: 17623837
[TBL] [Abstract][Full Text] [Related]
31. 5-Flourouracil in hepatocellular carcinoma: report of twenty-one cases.
Link JS; Bateman JR; Paroly WS; Durkin WJ; Peters RL
Cancer; 1977 May; 39(5):1936-9. PubMed ID: 192441
[TBL] [Abstract][Full Text] [Related]
32. Eleven years experience of oral urea treatment in liver malignancies.
Danopoulos ED; Danopoulou IE
Clin Oncol; 1981 Dec; 7(4):281-9. PubMed ID: 6274553
[No Abstract] [Full Text] [Related]
33. [Hepatic arterial infusion of etoposide in the treatment of primary liver neoplasms].
Yasuda H; Fujino H; Tagawa K; Unuma T
Gan To Kagaku Ryoho; 1990 Mar; 17(3 Pt 1):381-4. PubMed ID: 2155586
[TBL] [Abstract][Full Text] [Related]
34. A phase 2 study of cisplatin in patients with hepatocellular carcinoma.
Okada S; Okazaki N; Nose H; Shimada Y; Yoshimori M; Aoki K
Oncology; 1993; 50(1):22-6. PubMed ID: 7678453
[TBL] [Abstract][Full Text] [Related]
35. Phase I Study of Sorafenib in Combination with Intermittent Hepatic Arterial Infusion Chemotherapy for Unresectable Hepatocellular Carcinoma.
Ishizaki M; Kaibori M; Matsui K; Ikeda H; Yoshida K; Okazaki K; Kariya S; Tanigawa N; Nakatake R; Matsushima H; Sakaguchi T; Kon M
Cancer Invest; 2017 Apr; 35(4):271-276. PubMed ID: 28272913
[TBL] [Abstract][Full Text] [Related]
36. A phase II study of oral clofazimine in unresectable and metastatic hepatocellular carcinoma.
Ruff P; Chasen MR; Long JE; van Rensburg CE
Ann Oncol; 1998 Feb; 9(2):217-9. PubMed ID: 9553669
[TBL] [Abstract][Full Text] [Related]
37. Phase II trial of amsacrine in patients with hepatoma: a Cancer and Leukemia Group B study.
Amrein PC; Richards F; Coleman M; Poulin RF; Holland JF; Weinberg V; Perry M
Cancer Treat Rep; 1984 Jun; 68(6):923-4. PubMed ID: 6329510
[No Abstract] [Full Text] [Related]
38. [A case with hepatocellular carcinoma effectively treated by continuous hepatic arterial infusion of etoposide, epirubicin and CDDP].
Tarusawa K; Yodono H; Ikami I; Sasaki T; Kanehira J; Takahashi S; Shibutani K; Noda H; Shinohara A; Takekawa D
Gan To Kagaku Ryoho; 1992 Mar; 19(3):383-6. PubMed ID: 1311915
[TBL] [Abstract][Full Text] [Related]
39. First-in-class immune-modulating small molecule Icaritin in advanced hepatocellular carcinoma: preliminary results of safety, durable survival and immune biomarkers.
Fan Y; Li S; Ding X; Yue J; Jiang J; Zhao H; Hao R; Qiu W; Liu K; Li Y; Wang S; Zheng L; Ye B; Meng K; Xu B
BMC Cancer; 2019 Mar; 19(1):279. PubMed ID: 30922248
[TBL] [Abstract][Full Text] [Related]
40. [Treatment of liver metastatic ovarian cancer with sequential administration of OK-432 and etoposide].
Yakabe A; Ito T; Hayashi K; Yamashita S; Ito T; Sugino N
Nihon Gan Chiryo Gakkai Shi; 1990 Dec; 25(12):2843-7. PubMed ID: 1963633
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
